LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public ...

The average one-year price target for Biolase (NASDAQ:BIOL) has been revised to 275.40 / share. This is an increase of 9,900.00% from the prior estimate of 2.75 dated July 5, 2023. The price target is ...

Each unit of the 75,000 units consists of one share of Biolase’s series J convertible redeemable preferred stock, par value $0.001 per share, with a liquidation preference of $100 per share and one ...

Investors have turned a laser on Orange County medical device maker BioLase Technology Inc., which has beaten back several challenges during the past year. Shares of BioLase, which recently moved to ...

LAKE FOREST, Calif., Dec. 6, 2023 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a single ...

SAN DIEGO (CBS.MW) -- You've got to hand it to Biolase. The California maker of dental lasers pulled out all stops in an attempt to reignite its stock after warning that second-quarter earnings would ...

Irvine dental laser maker Biolase Technology Inc. is joining the Russell 2000 stock index next week, according to the company. The Russell 2000 index, part of Seattle-based Russell Investments, covers ...

LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public ...